Roots Analysis has done a detailed study on Medical Device Contract Manufacturing Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

To order this 590+ page report, which features 275+ figures and 290+ tables, please visit this link

 

Key Market Insights

• Over 270 companies worldwide have the necessary expertise and authorization to offer contract manufacturing services for various types of medical devices, including therapeutic and diagnostic products
• The market landscape is fragmented, featuring the presence of both established players and new entrants; presently, most medical device manufacturing facilities are located in the developed geographies
• Medical device CMOs are actively engaged in aligning their operations to comply to the standards established by various global and regional regulatory bodies
• Companies involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and comply to evolving industry benchmarks
• In the last six years, over 9,600 trials evaluating various medical devices have been registered by different types of sponsors covering a wide range of therapeutic areas
• Implants have emerged as one of the most prominent segments for which the acquisition activity is relatively higher; key value drivers behind such acquisitions include capability addition and geographical consolidation
• Driven by a rapidly growing demand, medical device contract services market is anticipated to grow at annualized rate of 8% for a variety of therapeutic areas and geographies for finished products
• Established CMOs currently occupy a major share; in the long term, the opportunity is anticipated to be better distributed across different types of companies, device classes and application areas

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/medical-device-contract-manufacturing-market-2019-2030/258.html

 

Table of Contents

 

1.                     PREFACE
1.1.                   Scope of the Report
1.2.                   Research Methodology
1.3.                   Chapter Outlines

2.                     EXECUTIVE SUMMARY

 

3.                     INTRODUCTION

3.1.                   Chapter Overview

3.2.                   Medical Devices: An Overview

3.2.1.                History of Medical Devices

3.2.2.                Classification of Medical Devices

3.3.                   Medical Device Manufacturing

3.3.1.                Challenges Associated with Medical Device Manufacturing

3.3.2.                Role of CMOs in Medical Device Manufacturing

3.3.3.                Role of Automation in Medical Device Manufacturing Process

3.4.                   Historical Timeline for Medical Device CMOs

3.5.                   Services Offered by Medical Device CMOs

3.6.                   Advantages Offered by Medical Device CMOs

3.7.                   Risks associated with Outsourcing to CMOs

3.8.                   Key Considerations

3.9.                   Concluding Remarks

 

4.                     REGULATORY LANDSCAPE FOR MEDICAL DEVICES

4.1.                   Chapter Overview

4.2.                   General Regulatory Guidelines for Medical Devices

 

4.3.                   Regulatory Landscape in North America

4.3.1.                The US Scenario

4.3.1.1.             Regulatory Authority

4.3.1.2.             Review / Approval Process

4.3.2.                The Canadian Scenario

4.3.2.1.             Regulatory Authority

4.3.2.2.             Review / Approval Process

 

4.4.                   Regulatory Landscape in Europe

4.4.1.                Overall Scenario

4.4.1.1.             Regulatory Authority

4.4.1.2.             Review / Approval Process

4.4.2.                Case Study: Brexit -The UK Scenario

 

4.5.                   Regulatory Landscape in Asia-Pacific

4.5.1.                The Chinese Scenario

4.5.1.1.             Regulatory Authority

4.5.1.2.             Review / Approval Process

4.5.2.                The Japanese Scenario

4.5.2.1.             Regulatory Authority

4.5.2.2.             Review / Approval Process

4.5.3.                The Australian Scenario

4.5.3.1.             Regulatory Authority

4.5.3.2.             Review / Approval Process

 

4.6.                   Comparison of Regional Regulatory Environment

 

5.                     MARKET OVERVIEW: THERAPEUTIC DEVICES

5.1.                   Chapter Overview

5.2.                   Medical Device CMOs Offering Services for Therapeutic Devices

5.2.1.                Analysis by Year of Establishment

5.2.2.                Analysis by Size of Employee Base

5.2.3.                Analysis by Location of Headquarters

5.2.4.                Analysis by Location of Manufacturing Facility

5.2.5.                Analysis by Regulatory Certifications / Accreditations

5.2.6.                Analysis by Production Services Offered

5.2.7.                Analysis by Post-production Services Offered

5.2.8.                Analysis by Other Services Offered

5.2.9.                Analysis by Device Class

5.2.10.              Analysis by Type of Material(s) Handled

5.2.11.              Analysis by Scale of Operation

5.2.12.              Leading Players

 

6.                     MARKET OVERVIEW: DIAGNOSTIC DEVICES

6.1.                   Chapter Overview

6.2.                   Medical Device CMOs Offering Services for Diagnostic Devices

6.2.1.                Analysis by Year of Establishment

6.2.2.                Analysis by Size of Employee Base

6.2.3.                Analysis by Location of Headquarters

6.2.4.                Analysis by Location of Manufacturing Facility

6.2.5.                Analysis by Regulatory Certifications / Accreditations

6.2.6.                Analysis by Production Services Offered

6.2.7.                Analysis by Post-Production Services Offered

6.2.8.                Analysis by Other Services Offered

6.2.9.                Analysis by Device Class

6.2.10.              Analysis by Type of Material(s) Handled

6.2.11.              Analysis by Scale of Operation

6.2.12.              Leading Players

 

7.                     MARKET OVERVIEW: DELIVERY SYSTEMS AND OTHERS

7.1.                   Chapter Overview

7.2.                   Catheters

7.2.1.                Medical Device CMOs Offering Services for Catheters

7.2.2.                Analysis by Year of Establishment

7.2.3.                Analysis by Size of Employee Base

7.2.4.                Analysis by Location of Headquarters

7.2.5.                Analysis by Location of Manufacturing Facility

7.2.6.                Analysis by Regulatory Certifications / Accreditations

7.2.7.                Analysis by Production Services Offered

7.2.8.                Analysis by Post-Production Services Offered

7.2.9.                Analysis by Other Services Offered

7.2.10.              Analysis by Device Class

7.2.11.              Analysis by Type of Material(s) Handled

7.2.12.              Analysis by Scale of Operation

7.2.13.              Leading Players

 

7.3.                   Drug Delivery Devices

7.3.1.                Medical Device CMOs Offering Services for Drug Delivery Devices

7.3.2.                Analysis by Year of Establishment

7.3.3.                Analysis by Size of Employee Base

7.3.4.                Analysis by Location of Headquarters

7.3.5.                Analysis by Location of Manufacturing Facility

7.3.6.                Analysis by Regulatory Certifications / Accreditations

7.3.7.                Analysis by Production Services Offered

7.3.8.                Analysis by Post-Production Services Offered

7.3.9.                Analysis by Other Services Offered

7.3.10.              Analysis by Device Class

7.3.11.              Analysis by Type of Material(s) Handled

7.3.12.              Analysis by Scale of Operation

7.3.13.              Leading Players

 

7.4.                   Other Devices

7.4.1.                Medical Device CMOs Offering Services for Other Medical Devices

7.4.2.                Analysis by Year of Establishment

7.4.3.                Analysis by Size of Employee Base

7.4.4.                Analysis by Location of Headquarters

7.4.5.                Analysis by Location of Manufacturing Facility

7.4.6.                Analysis by Regulatory Certifications / Accreditations

7.4.7.                Analysis by Production Services Offered

7.4.8.                Analysis by Post-Production Services Offered

7.4.9.                Analysis by Other Services Offered

7.4.10.              Analysis by Device Class

7.4.11.              Analysis by Type of Material(s) Handled

7.4.12.              Analysis by Scale of Operation

 

8.                     BENCHMARK ANALYSIS

8.1.                   Chapter Overview

8.2.                   Benchmark Analysis: Methodology

 

8.3.                   Region-wise Benchmark Analysis

8.3.1.                North America, Peer Group I

8.3.2.                North America, Peer Group II

8.3.3.                North America, Peer Group III

8.3.4.                North America, Peer Group IV

8.3.5.                North America, Peer Group V

8.3.6.                North America, Peer Group VI

8.3.7.                North America, Peer Group VII

8.3.8.                Europe, Peer Group VIII

8.3.9.                Europe, Peer Group IX

8.3.10.              Europe, Peer Group X

8.3.11.              Asia, Peer Group XI

8.3.12.              Asia, Peer Group XII

8.4.                   Concluding Remarks

 

9.                     SUPPLY CHAIN ANALYSIS

9.1.                   Chapter Overview

9.2.                   Overview of the Medical Device Supply Chain

9.3.                   Factors Affecting the Medical Device Supply Chain

9.4.                   Key Performance Indicators

 

9.5.                   Supply Chain Improvement Strategies

9.5.1.                Optimization of Supply Chain Capabilities

9.5.2.                Visible Supply Chain and Related Advantages

9.5.2.1.             Augmenting Supply Chain Visibility Through Digitalization

9.5.2.2.             Benefits of Digital Supply Chain

 

9.6.                   Effects of Supply Chain Optimization

 

9.7.                   Cost Analysis

9.7.1.                Production-related Costs

9.7.1.1.             Labor Costs

9.7.1.2.             Raw Materials Related Costs

9.7.1.3.             Regulatory Compliance

9.7.1.4.             Technology-related Costs

9.7.2.                Supply Chain-related Costs

9.7.2.1.             Local Presence

9.7.2.2.             Geopolitical Risk

9.7.2.3.             Logistics

 

10.                    COMPANY PROFILES

10.1.                 Chapter Overview

10.2.                 CMOs Headquartered in North America

10.2.1.              Cirtec Medical

10.2.1.1.           Company Overview

10.2.1.2.           Service Portfolio

10.2.1.3.           Manufacturing Capabilities and Facilities

10.2.1.3.1.         Facilities located in North America

10.2.1.3.2.         Facilities Located in Europe

10.2.1.4.           Future Outlook

 

10.2.2.              DynaFlex Technologies

10.2.2.1.           Company Overview

10.2.2.2.           Service Portfolio

10.2.2.3.           Manufacturing Capabilities and Facilities

10.2.2.4.           Future Outlook

 

10.2.3.              I-Tek Medical Technologies

10.2.3.1.           Company Overview

10.2.3.2.           Service Portfolio

10.2.3.3.           Manufacturing Capabilities and Facilities

10.2.3.4.           Future Outlook

 

10.2.4.              Keystone Solutions Group

10.2.4.1.           Company Overview

10.2.4.2.           Service portfolio

10.2.4.3.           Manufacturing Facilities

10.2.4.4.           Future Outlook

 

10.2.5.              Oscor

10.2.5.1.           Company Overview

10.2.5.2.           Service Portfolio

10.2.5.3.           Manufacturing Capabilities and facilities

10.2.5.4.           Future Outlook

 

10.2.6.              SMC

10.2.6.1.           Company Overview

10.2.6.2.           Service Portfolio

10.2.6.3.           Manufacturing Capabilities and facilities

10.2.6.3.1.         Facilities Located in North America

10.2.6.3.2.         Facility Located in Central America

10.2.6.3.3.         Facility Located in Europe

10.2.6.3.4.         Facility Located in Asia

10.2.6.4.           Future Outlook

 

10.2.7.              Stellartech Research

10.2.7.1.           Company Overview

10.2.7.2.           Service Portfolio

10.2.7.3.           Manufacturing Capabilities and facilities

10.2.7.4.           Future Outlook

 

10.3.                 CMOs Headquartered in Europe

10.3.1.              Creganna Medical

10.3.1.1.           Company Overview

10.3.1.2.           Service Portfolio

10.3.1.3.           Manufacturing Facilities

10.3.1.3.1.         Facilities Located in North America

10.3.1.3.2.         Facilities Located in Central America

10.3.1.3.3.         Facilities Located in Europe

10.3.1.3.4.         Facilities Located in Asia

10.3.1.4.           Future Outlook

 

10.3.2.              Europlaz Technologies

10.3.2.1.           Company Overview

10.3.2.2.           Service Portfolio

10.3.2.3.           Manufacturing facilities

10.3.2.4.           Future Outlook

 

10.3.3.              Riverside Medical Packaging

10.3.3.1.           Company Overview

10.3.3.2.           Service Portfolio

10.3.3.3.           Manufacturing Facilities

10.3.3.4.           Future Outlook

 

10.3.4.              Synecco

10.3.4.1.           Company Overview

10.3.4.2.           Service Portfolio

10.3.4.3.           Manufacturing Facilities

10.3.4.3.1.         Facilities Located in Europe

10.3.4.3.2.         Facilities Located in Asia

10.3.4.4.           Future Outlook

 

10.3.5.              Trelleborg Sealing Solutions

10.3.5.1.           Company Overview

10.3.5.2.           Service Portfolio

10.3.5.3.           Manufacturing Facilities

10.3.5.3.1.         Facilities Located in North America

10.3.5.3.2.         Facilities Located in Europe

10.3.5.4.           Future Outlook

 

10.4.                 CMOs Headquartered in Asia

10.4.1.              Interplex

10.4.1.1.           Company Overview

10.4.1.2.           Service Portfolio

10.4.1.3.           Manufacturing Facilities

10.4.1.3.1.         Facilities Located in North America

10.4.1.3.2.         Facilities Located in Europe

10.4.1.3.3.         Facilities Located in Asia

10.4.1.4.           Future Outlook

 

10.4.2.              Modern Medical

10.4.2.1.           Company Overview

10.4.2.2.           Service Portfolio

10.4.2.3.           Manufacturing facilities

10.4.2.4.           Future Outlook

10.4.3.              Providence Enterprise

10.4.3.1.           Company Overview

10.4.3.2.           Service Portfolio

10.4.3.3.           Manufacturing Facilities

10.4.3.4.           Future Outlook

 

10.4.4.              Suzhou Jenitek

10.4.4.1.           Company overview

10.4.4.2.           Service Portfolio

10.4.4.3.           Manufacturing Facilities

10.4.4.4.           Future Outlook

 

11.                    CLINICAL TRIAL ANALYSIS

11.1.                 Chapter Overview

11.2.                 Scope and Methodology

11.3.                 Clinical Trial Analysis: Word Cloud of Trial Titles

 

11.4.                 Analysis of Clinical Trials

11.4.1.              Analysis by Trial Start Year

11.4.2.              Analysis by Trial Status

11.4.3.              Analysis by Phase of Development

11.4.4.              Analysis by Target Indication

11.4.5.              Analysis by Type of Sponsor

11.4.6.              Analysis by Geography

11.4.7.              Analysis by Trial Start Year and Geography

 

11.5.                 Analysis of Enrolled Patient Population

11.5.1.              Analysis by Trial Status

11.5.2.              Analysis by Phase of Development

11.5.3.              Analysis by Geography

 

11.6.                 Analysis of Focus Therapeutic Areas

11.6.1.              Analysis by Type of Sponsor

11.6.2.              Analysis by Geography

11.6.2.1.           North American Scenario

11.6.2.2.           European Scenario

11.6.2.3.           Asia Pacific Scenario

11.6.2.4.           Rest of the World Scenario

 

11.6.3.              Cardiovascular Disorders

11.6.3.1.           Analysis by Trial Start Year

11.6.3.2.           Analysis by Type of Sponsor

11.6.3.3.           Analysis by Geography

 

11.6.4.              Oncological Disorders

11.6.4.1.           Analysis by Trial Start Year

11.6.4.2.           Analysis by Type of Sponsor

11.6.4.3.           Analysis by Geography

 

11.6.5.              Central Nervous System (CNS) Disorders

11.6.5.1.           Analysis by Trial Start Year

11.6.5.2.           Analysis by Type of Sponsor

11.6.5.3.           Analysis by Geography

 

11.6.6.              Orthopedic Disorders

11.6.6.1.           Analysis by Trial Start Year

11.6.6.2.           Analysis by Type of Sponsor

11.6.6.3.           Analysis by Geography

 

11.6.7.              Respiratory Disorders

11.6.7.1.           Analysis by Trial Start Year

11.6.7.2.           Analysis by Type of Sponsor

11.6.7.3.           Analysis by Geography

 

12.                    MERGERS AND ACQUISITIONS

12.1.                 Chapter Overview

12.2.                 Merger and Acquisition Models

12.3.                 Medical Device Contract Manufacturing: Mergers and Acquisitions

12.3.1.              Analysis by Year of Mergers and Acquisitions

12.3.2.              Analysis by Type of Acquisition

12.3.3.              Most Active Acquirers: Analysis by Number of Acquisitions

12.3.4.              Analysis by Key Value Drivers

12.3.4.1.           Continent-wise distribution

12.3.4.2.           Intercontinental and Intracontinental Deals

12.3.4.3.           Country-wise distribution

 

12.3.5.              Ownership Change Matrix

12.3.6.              Acquisitions Made by Medical Device Companies

12.3.6.1.           Acquisition of Entire Company

12.3.6.1.1.         Analysis by Key Value Drivers

12.3.6.1.2.         Analysis by Key Value Drivers and Year of Acquisition

12.3.6.1.3.         Analysis by Type of Services Offered

12.3.6.1.4.         Analysis by Type of Device

12.3.6.1.5.         Analysis by Therapeutic Area

12.3.6.2.           Acquisition of Company Assets

12.3.6.2.1.         Analysis by Key Value Drivers

12.3.6.2.2.         Analysis by Key Value Drivers and Year of Acquisition

 

12.3.7.              Acquisition by Private Equity Firms

12.3.7.1.           Analysis by Year of Acquisition

12.3.7.2.           Analysis by Type of Acquisition

12.3.7.3.           Analysis by Type of Device

12.3.7.4.           Analysis by Therapeutic Area

 

12.4.                 Key Acquisitions: Deal Multiples

12.4.1.              Analysis by Revenues

 

13.                    CASE STUDY: OFFSHORING MEDICAL DEVICE CONTRACT MANUFACTURING

13.1.                 Chapter Overview

13.2.                 Emerging Markets: Definitions and Key Regions

13.3.                 Role of Emerging Markets in Industrial Manufacturing

13.3.1.              Contributions to the Automobile Industry

13.3.2.              Contributions to the Aerospace and Defense Industries

13.4.                 Medical Devices Manufacturing in Emerging Markets

13.4.1.              The US-Chinese Scenario

13.4.2.              Partnership with Companies in Emerging Markets

 

13.5.                 Multinational Companies Focused on Manufacturing Medical Devices in Emerging           Markets

 

13.6.                 Business Models for Medical Device Manufacturing in Emerging Markets

13.6.1.              Case Studies

13.6.1.1.           Study A: Overview

13.6.1.1.1.         Value Proposition

13.6.1.1.2.         Value Creation

13.6.1.2.           Study B: Overview

13.6.1.2.1.         Value Proposition

13.6.1.2.2.         Value Creation

 

13.7.                 Key Challenges related to Innovation in the Medical Device Industry

13.7.1.              Limitations of In-House Innovation

13.8.                 Advantages of Establishing Innovation Hubs in Emerging Markets

13.8.1.              Challenges and Market Restraints

13.8.2.              Strategies to Address Existing Challenges

13.9.                 Future Perspectives

 

14.                    MARKET FORECAST

14.1.                 Chapter Overview

14.2.                 Forecast Methodology and Key Assumptions

 

14.3.                 Overall Medical Device Contract Manufacturing Market, 2019-2030

14.3.1.              Medical Device Contract Manufacturing Market:  Distribution by Application                                 Areas, 2019, 2025 and 2030

14.3.1.1.           Medical Device Contract Manufacturing Market for Therapeutic Devices, 2019-                             2030

14.3.1.2.           Medical Device Contract Manufacturing Market for Diagnostic Devices, 2019-                              2030

14.3.1.3.           Medical Device Contract Manufacturing Market for Drug Delivery Devices, 2019-                          2030

14.3.1.4.           Medical Device Contract Manufacturing Market for Other Devices, 2019-2030

 

14.3.2.              Medical Device Contract Manufacturing Market:  Distribution by Device Class,                              2019 and 2030

14.3.2.1.           Medical Device Contract Manufacturing Market: Class I Devices, 2019-2030

14.3.2.2.           Medical Device Contract Manufacturing Market: Class II Devices, 2019-2030

14.3.2.3.           Medical Device Contract Manufacturing Market: Class III Devices, 2019-2030

 

14.3.3.              Medical Device Contract Manufacturing Market:  Leading Players, 2019-2030

 

14.3.4.              Medical Device Contract Manufacturing Market: Distribution by Therapeutic                                 Areas, 2019 and 2030

14.3.4.1.           Medical Device Contract Manufacturing Market for Cardiovascular Disorders,                               2019-2030

14.3.4.2.           Medical Device Contract Manufacturing Market for CNS Disorders, 2019-2030

14.3.4.3.           Medical Device Contract Manufacturing Market for Metabolic Disorders, 2019-                             2030

14.3.4.4.           Medical Device Contract Manufacturing Market for Oncological Disorders, 2019-                          2030

14.3.4.5.           Medical Device Contract Manufacturing Market for Orthopedic Disorders, 2019-                           2030

14.3.4.6.           Medical Device Contract Manufacturing Market for Ophthalmic Disorders, 2019-                           2030

14.3.4.7.           Medical Device Contract Manufacturing Market for Pain Disorders, 2019-2030

14.3.4.8.           Medical Device Contract Manufacturing Market for Respiratory Disorders, 2019-                           2030

14.3.4.9.           Medical Device Contract Manufacturing Market for Other Therapeutic Areas,                                2019-2030

 

14.4.                 Medical Device Contract Manufacturing Market: Distribution by Geography,                                 2019, 2025 and 2030

14.4.1.              Medical Device Contract Manufacturing Market in North America, 2019-2030

14.4.1.1.           Medical Device Contract Manufacturing Market in the US, 2019-2030

14.4.1.2.           Medical Device Contract Manufacturing Market in Rest of North America, 2019-                            2030

14.4.1.3.           Medical Device Contract Manufacturing Market in North America: Class I                                     Devices, 2019-2030

14.4.1.4.           Medical Device Contract Manufacturing Market in North America: Class II                                    Devices, 2019-2030

14.4.1.5.           Medical Device Contract Manufacturing Market in North America: Class III                                   Devices, 2019-2030

14.4.1.6.           Medical Device Contract Manufacturing Market in North America for                                            Cardiovascular Disorders, 2019-2030

14.4.1.7.           Medical Device Contract Manufacturing Market in North America for CNS                                    Disorders, 2019-2030

14.4.1.8.           Medical Device Contract Manufacturing Market in North America for Metabolic                             Disorders, 2019-2030

14.4.1.9.           Medical Device Contract Manufacturing Market in North America for Oncological                          Disorders, 2019-2030

14.4.1.10.          Medical Device Contract Manufacturing Market in North America for Orthopedic                           Disorders, 2019-2030

14.4.1.11.          Medical Device Contract Manufacturing Market in North America for Ophthalmic                           Disorders, 2019-2030

14.4.1.12.          Medical Device Contract Manufacturing Market in North America for Pain                                     Disorders, 2019-2030

14.4.1.13.          Medical Device Contract Manufacturing Market in North America for Respiratory Disorders, 2019-2030

14.4.1.14.          Medical Device Contract Manufacturing Market for Other Therapeutic Areas in                             North America, 2019-2030

 

14.4.2.              Medical Device Contract Manufacturing Market in Europe, 2019-2030

14.4.2.1.           Medical Device Contract Manufacturing Market in Italy, 2019-2030

14.4.2.2.           Medical Device Contract Manufacturing Market in Germany, 2019-2030

14.4.2.3.           Medical Device Contract Manufacturing Market in France, 2019-2030

14.4.2.4.           Medical Device Contract Manufacturing Market in Spain, 2019-2030

14.4.2.5.           Medical Device Contract Manufacturing Market in the UK, 2019-2030

14.4.2.6.           Medical Device Contract Manufacturing Market in Rest of Europe, 2019-2030

14.4.2.7.           Medical Device Contract Manufacturing Market in Europe: Class I Devices, 2019-                         2030

14.4.2.8.           Medical Device Contract Manufacturing Market in Europe: Class II Devices,                                 2019-2030

14.4.2.9.           Medical Device Contract Manufacturing Market in Europe: Class III Devices,                                2019-2030

14.4.2.10.          Medical Device Contract Manufacturing Market in Europe for Cardiovascular                                Disorders, 2019-2030

14.4.2.11.          Medical Device Contract Manufacturing Market in Europe for CNS Disorders,                               2019-2030

14.4.2.12.          Medical Device Contract Manufacturing Market in Europe for Metabolic                                       Disorders, 2019-2030

14.4.2.13.          Medical Device Contract Manufacturing Market in Europe for Oncological                                    Disorders, 2019-2030

14.4.2.14.          Medical Device Contract Manufacturing Market in Europe for Orthopedic                                     Disorders, 2019-2030

14.4.2.15.          Medical Device Contract Manufacturing Market in Europe for Ophthalmic                                     Disorders, 2019-2030

14.4.2.16.          Medical Device Contract Manufacturing Market in Europe for Pain Disorders,                               2019-2030

14.4.2.17.          Medical Device Contract Manufacturing Market in Europe for Respiratory                                     Disorders, 2019-2030

14.4.2.18.          Medical Device Contract Manufacturing Market in Europe for Other Therapeutic                           Areas, 2019-2030

 

14.4.3.              Medical Device Contract Manufacturing Market in Asia Pacific, 2019-2030

14.4.3.1.           Medical Device Contract Manufacturing Market in China, 2019-2030

14.4.3.2.           Medical Device Contract Manufacturing Market in Japan, 2019-2030

14.4.3.3.           Medical Device Contract Manufacturing Market in India, 2019-2030

14.4.3.4.           Medical Device Contract Manufacturing Market in Rest of Asia Pacific, 2019-                               2030

14.4.3.5.           Medical Device Contract Manufacturing Market in Asia Pacific: Class I Devices,                           2019-2030

14.4.3.6.           Medical Device Contract Manufacturing Market in Asia Pacific: Class II Devices,                           2019-2030

14.4.3.7.           Medical Device Contract Manufacturing Market in Asia Pacific: Class III Devices,                          2019-2030

14.4.3.8.           Medical Device Contract Manufacturing Market in Asia Pacific for Cardiovascular                         Disorders, 2019-2030

14.4.3.9.           Medical Device Contract Manufacturing Market in Asia Pacific for CNS                                        Disorders, 2019-2030

14.4.3.10.          Medical Device Contract Manufacturing Market in Asia Pacific for Metabolic                                 Disorders, 2019-2030

14.4.3.11.          Medical Device Contract Manufacturing Market in Asia Pacific for Oncological                              Disorders, 2019-2030

14.4.3.12.          Medical Device Contract Manufacturing Market in Asia Pacific for Orthopedic                               Disorders, 2019-2030

14.4.3.13.          Medical Device Contract Manufacturing Market in Asia Pacific for Ophthalmic                              Disorders, 2019-2030

14.4.3.14.          Medical Device Contract Manufacturing Market in Asia Pacific for Pain Disorders,                        2019-2030

14.4.3.15.          Medical Device Contract Manufacturing Market in Asia Pacific for Respiratory                              Disorders, 2019-2030

14.4.3.16.          Medical Device Contract Manufacturing Market in Asia Pacific for Other                                       Therapeutic Areas, 2019-2030

 

14.4.4.              Medical Device Contract Manufacturing Market in Rest of the World, 2019-2030

14.4.4.1.           Medical Device Contract Manufacturing Market in Rest of the World: Class I                                 Devices, 2019-2030

14.4.4.2.           Medical Device Contract Manufacturing Market in Rest of the World: Class II                                Devices, 2019-2030

14.4.4.3.           Medical Device Contract Manufacturing Market in Rest of the World: Class III                               Devices, 2019-2030

14.4.4.4.           Medical Device Contract Manufacturing Market in Rest of the World for                                        Cardiovascular Disorders, 2019-2030

14.4.4.5.           Medical Device Contract Manufacturing Market in Rest of the World for CNS                                Disorders, 2019-2030

14.4.4.6.           Medical Device Contract Manufacturing Market in Rest of the World for                                        Metabolic Disorders, 2019-2030

14.4.4.7.           Medical Device Contract Manufacturing Market in Rest of the World for                                        Oncological Disorders, 2019-2030

14.4.4.8.           Medical Device Contract Manufacturing Market in Rest of the World for                                        Orthopedic Disorders, 2019-2030

14.4.4.9.           Medical Device Contract Manufacturing Market in Rest of the World for                                        Ophthalmic Disorders, 2019-2030

14.4.4.10.          Medical Device Contract Manufacturing Market in Rest of the World for Pain                                Disorders, 2019-2030

14.4.4.11.          Medical Device Contract Manufacturing Market in Rest of the World for                                        Respiratory Disorders, 2019-2030

14.4.4.12.          Medical Device Contract Manufacturing Market in Rest of the World for Other                               Therapeutic Areas, 2019-2030

 

15.                    SWOT ANALYSIS

15.1.                 Chapter Overview

15.2.                 Strengths

15.3.                 Weaknesses

15.4.                 Opportunities

15.5.                 Threats

15.6.                 Concluding Remarks

 

16.                    CONCLUSION

16.1.                 Chapter Overview

16.2.                 Key Takeaways

 

17.                    SURVEY / INTERVIEW TRANSCRIPTS

 

18.                    APPENDIX 1: TABULATED DATA 

 

19.                    APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com